Report      Database

    Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands)

    Date: 19 Jan, 2017              Type: Diagnostics              Pages: 120

    Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands)
    • Electronic Access - Single User License
      $1,250.00
    • CD-ROM Mail Delivery
      $1,350.00
    • Hard-copy Mail Delivery
      $1,400.00
    • Electronic Access - Multi User License
      $2,050.00

    Get Free 10% Customization in This Report

    Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) is 119 Page market research report with 115 Figures and 2 Tables published by Renub Research.

    Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incidence rate in Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom are top three dominating countries in the Europe cervical cancer market in 2015.

    All the 9 countries in the report have been studied from 3 viewpoints.

    Cervical Cancer Test Market, Population & Mortality

     

    1.    Cervical Cancer Test Population (2008-2020)

    •  Pap Smear Test Population & Forecast
    •  HPV DNA Test Population & Forecast 

    2.    Cervical Cancer Mortality Population (2001-2011)

    3.    Cervical Cancer Test Market (2008-2020)

    • Pap Smear Test Market & Forecast
    • HPV DNA Test Market & Forecast

     

    9 Countries studied in the report are as follows

    1.    United Kingdom
    2.    France
    3.    Germany
    4.    Italy
    5.    Spain
    6.    Sweden
    7.    Switzerland
    8.    Norway
    9.    Netherlands
     

    Data Sources

    This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

    Primary sources include industry surveys and telephone interviews with industry experts.

    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

     

    1.    Executive Summary

    2.    Europe Cervical Cancer Test (Screening) Population & Forecast

    3.    Europe Cervical Cancer Test (Screening) Market & Forecast
    3.1    Europe Cervical Cancer Pap Smear Test (Screening) Market & Forecast

    3.2    Europe Cervical Cancer HPV DNA Test (Screening) Market & Forecast

    4.    Europe Cervical Cancer Test (Screening) Population Share, Market Share & Forecast
    4.1    Europe Cervical Cancer Test (Screening) Population Share & Forecast

    4.2    Europe Cervical Cancer Test (Screening) Market Share & Forecast

    4.3    Europe Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast

    4.4    Europe Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast

    5.    United Kingdom – Cervical Cancer Test Analysis
    5.1    United Kingdom Cervical Cancer Test (Screening) Population
    5.1.1    United Kingdom Cervical Cancer Pap Smear Test Population & Forecast
    5.1.2    United Kingdom Cervical Cancer HPV DNA Test Population & Forecast

    5.2    United Kingdom Cervical Cancer Deaths

    5.3    United Kingdom Cervical Cancer Test (Screening) Analysis
    5.3.1    United Kingdom Cervical Cancer Test Market & Forecast
    5.3.2    United Kingdom Pap Smear Test Market & Forecast
    5.3.3    United Kingdom HPV DNA Test Market & Forecast

    6.    France – Cervical Cancer Test Analysis
    6.1    France Cervical Cancer Test (Screening) Population
    6.1.1    France Cervical Cancer Pap Smear Test Population & Forecast
    6.1.2    France Cervical Cancer HPV DNA Test Population & Forecast

    6.2    France Cervical Cancer Mortality

    6.3    France Cervical Cancer Test (Screening) Analysis
    6.3.1    France Cervical Cancer Test Market & Forecast
    6.3.2    France Pap Smear Test Market & Forecast
    6.3.3    France HPV DNA Test Market & Forecast

    7.    Germany – Cervical Cancer Test Analysis
    7.1    Germany Cervical Cancer Test (Screening) Population
    7.1.1    Germany Cervical Cancer Pap Smear Test Population & Forecast
    7.1.2    Germany Cervical Cancer HPV DNA Test Population & Forecast

    7.2    Germany Cervical Cancer Mortality

    7.3    Germany Cervical Cancer Test (Screening) Market
    7.3.1    Germany Cervical Cancer Test Market & Forecast
    7.3.2    Germany Pap Smear Test Market & Forecast
    7.3.3    Germany HPV DNA Test Market & Forecast

    8.    Italy – Cervical Cancer Test Analysis
    8.1    Italy Cervical Cancer Test (Screening) Population
    8.1.1    Italy Cervical Cancer Pap Smear Test Population & Forecast
    8.1.2    Italy Cervical Cancer HPV DNA Test Population & Forecast

    8.2    Italy Cervical Cancer Mortality

    8.3    Italy Cervical Cancer Test (Screening) Market
    8.3.1    Italy Cervical Cancer Test Market & Forecast
    8.3.2    Italy Pap Smear Test Market & Forecast
    8.3.3    Italy HPV DNA Test Market & Forecast

    9.    Spain – Cervical Cancer Test Analysis
    9.1    Spain Cervical Cancer Test (Screening) Population
    9.1.1    Spain Cervical Cancer Pap Smear Test Population & Forecast
    9.1.2    Spain Cervical Cancer HPV DNA Test Population & Forecast

    9.2    Spain Cervical Cancer Mortality

    9.3    Spain Cervical Cancer Test (Screening) Market
    9.3.1    Spain Cervical Cancer Test Market & Forecast
    9.3.2    Spain Pap Smear Test Market & Forecast
    9.3.3    Spain HPV DNA Test Market & Forecast

    10.    Sweden – Cervical Cancer Test Analysis
    10.1    Sweden Cervical Cancer Test (Screening) Population
    10.1.1    Sweden Cervical Cancer Pap Smear Test Population & Forecast
    10.1.2    Sweden Cervical Cancer HPV DNA Test Population & Forecast

    10.2    Sweden Cervical Cancer Mortality

    10.3    Sweden Cervical Cancer Test (Screening) Market
    10.3.1    Sweden Cervical Cancer Test Market & Forecast
    10.3.2    Sweden Pap Smear Test Market & Forecast
    10.3.3    Sweden HPV DNA Test Market & Forecast

    11.    Switzerland – Cervical Cancer Test Analysis
    11.1    Switzerland Cervical Cancer Test (Screening) Population
    11.1.1    Switzerland Cervical Cancer Pap Smear Test Population & Forecast
    11.1.2    Switzerland Cervical Cancer HPV DNA Test Population & Forecast

    11.2    Switzerland Cervical Cancer Mortality

    11.3    Switzerland Cervical Cancer Test (Screening) Market
    11.3.1    Switzerland Cervical Cancer Test Market & Forecast
    11.3.2    Switzerland Pap smear Test Market & Forecast
    11.3.3    Switzerland HPV DNA Test Market & Forecast

    12.    Norway – Cervical Cancer Test Analysis
    12.1    Norway Cervical Cancer Test (Screening) Population
    12.1.1    Norway Cervical Cancer Pap Smear Test Population & Forecast
    12.1.2    Norway Cervical Cancer HPV DNA Test Population & Forecast

    12.2    Norway Cervical Cancer Mortality

    12.3    Norway Cervical Cancer Test (Screening) Market
    12.3.1    Norway Cervical Cancer Test Market & Forecast
    12.3.2    Norway Pap Smear Test Market & Forecast
    12.3.3    Norway HPV DNA Test Market & Forecast

    13.    Netherlands – Cervical Cancer Test Analysis
    13.1    Netherlands Cervical Cancer Test (Screening) Population
    13.1.1    Netherlands Cervical Cancer Pap Smear Test Population & Forecast
    13.1.2    Netherlands Cervical Cancer HPV DNA Test Population & Forecast

    13.2    Netherlands Cervical Cancer Mortality

    13.3    Netherlands Cervical Cancer Test (Screening) Market
    13.3.1    Netherlands Cervical Cancer Test Market & Forecast
    13.3.2    Netherlands Pap Smear Test Market & Forecast
    13.3.3    Netherlands HPV DNA Test Market & Forecast

    14.    Cervical Cancer Test Market Growth Drivers
    14.1    Rising Cases of Teenage Sexual Cases Globally

    14.2    Huge Prevalence of HPV Infected Patients Globally

    15.    Challenges in Cervical Cancer Test Market
    15.1    Introduction of HPV Vaccination Programs Globally

     

    List of Figures

    Figure 2 1: Europe – Cervical Cancer Test Population (Million), 2008 – 2015
    Figure 2 2: Europe – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020

    Figure 3 1: Europe – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 3 2: Europe – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 3 3: Europe – Cervical Cancer Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 3 4: Europe – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 3 5: Europe – Cervical Cancer HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 3 6: Europe – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 4 1: Europe – Cervical Cancer Test Population Share (Percent), 2008 – 2015
    Figure 4 2: Europe – Forecast for Cervical Cancer Test Population Share (Percent), 2016 – 2020
    Figure 4 3: Europe – Cervical Cancer Test Market Share (Percent), 2008 – 2015
    Figure 4 4: Europe – Forecast for Cervical Cancer Test Market Share (Percent), 2016 – 2020
    Figure 4 5: Europe – Cervical Cancer Pap Smear Test Market Share (Percent), 2008 – 2015
    Figure 4 6: Europe – Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 – 2020
    Figure 4 7: Europe – Cervical Cancer HPV DNA Test Market Share (Percent), 2008 – 2015
    Figure 4 8: Europe – Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 – 2020

    Figure 5 1: United Kingdom – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 5 2: United Kingdom – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 5 3: United Kingdom – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 5 4: United Kingdom – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 5 5: United Kingdom – Cervical Cancer Deaths (Number), 2001 – 2011
    Figure 5 6: United Kingdom – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 5 7: United Kingdom – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 5 8: United Kingdom – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 5 9: United Kingdom – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 5 10: United Kingdom – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 5 11: United Kingdom – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 6 1: France – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 6 2: France – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 6 3: France – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 6 4: France – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 6 5: France – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 6 6: France – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 6 7: France – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 6 8: France – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 6 9: France – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 6 10: France – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 6 11: France – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 7 1: Germany – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 7 2: Germany – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 7 3: Germany – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013
    Figure 7 4: Germany – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020
    Figure 7 5: Germany – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 7 6: Germany – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 7 7: Germany – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 7 8: Germany – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 7 9: Germany – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 7 10: Germany – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 7 11: Germany – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 8 1: Italy – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 8 2: Italy – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 8 3: Italy – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 8 4: Italy – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 8 5: Italy – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 8 6: Italy – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 8 7: Italy – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 8 8: Italy – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 8 9: Italy – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 8 10: Italy – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 8 11: Italy – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 9 1: Spain – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 9 2: Spain – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 9 3: Spain – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 9 4: Spain – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 –2020
    Figure 9 5: Spain – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 9 6: Spain – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 9 7: Spain – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 9 8: Spain – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 9 9: Spain – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 9 10: Spain – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 9 11: Spain – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 10 1: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 10 2: Sweden – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 10 3: Sweden – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 10 4: Sweden – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 10 5: Sweden – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 10 6: Sweden – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 10 7: Sweden – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 10 8: Sweden – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 10 9: Sweden – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 10 10: Sweden – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 10 11: Sweden – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 11 1: Switzerland – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 11 2: Switzerland – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 11 3: Switzerland – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 11 4: Switzerland – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 11 5: Switzerland – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 11 6: Switzerland – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 11 7: Switzerland – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 11 8: Switzerland – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 11 9: Switzerland – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 11 10: Switzerland – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 11 11: Switzerland – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 12 1: Norway – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 12 2: Norway – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 12 3: Norway – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 12 4: Norway – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 12 5: Norway – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 12 6: Norway – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 12 7: Norway – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 12 8: Norway – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 12 9: Norway – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 12 10: Norway – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 12 11: Norway – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 13 1: Netherlands – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 13 2: Netherlands – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 13 3: Netherlands – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 13 4: Netherlands – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 13 5: Netherlands – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 13 6: Netherlands – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 13 7: Netherlands – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 13 8: Netherlands – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 13 9: Netherlands – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 13 10: Netherlands – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 13 11: Netherlands – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020



    List of Tables

    Table 25 3: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006
    Table 25 4: Worldwide – HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010

     


    Related Products